Capricor Therapeutics
CAPR
#7980
Rank
A$0.43 B
Marketcap
A$9.57
Share price
-4.36%
Change (1 day)
-59.13%
Change (1 year)

Capricor Therapeutics (CAPR) - Net assets

Net assets on the balance sheet as of September 2025 : A$0.12 Billion

According to Capricor Therapeutics 's latest financial reports the company has A$0.12 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Capricor Therapeutics - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$0.23 B604.96%
2023-12-31$A$33.17 M91.54%
2022-12-31$A$17.31 M-59.97%
2021-12-31$A$43.26 M17.98%
2020-12-31$A$36.67 M275.43%
2019-12-31$A$9.76 M49.1%
2018-12-31$A$6.55 M-54.44%
2017-12-31$A$14.38 M-358.94%
2016-12-31$-A$5.56 Million292.11%
2015-12-31$-A$1.42 Million-81.45%
2014-12-31$-A$7.64 Million1173.28%
2013-12-31$-A$0.6 Million-112.73%
2012-12-31$A$4.7 M481.32%
2011-12-31$A$0.81 M-68.31%
2010-12-31$A$2.55 M-22.99%
2009-12-31$A$3.31 M-54.11%
2008-12-31$A$7.23 M-58.39%
2007-12-31$A$17.38 M-10268.67%
2006-12-31$-A$0.18 Million61.16%
2005-12-31$-A$0.11 Million39.71%
2004-12-31$-A$0.08 Million38.73%
2003-12-31$-A$0.06 Million25.72%
2002-12-31$-A$0.05 Million148.48%
2001-12-31$-A$0.02 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Cytokinetics
CYTK
-A$0.79 Billion-721.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-A$9.62 Million-107.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$119.33 B 94,426.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$4.52 B 3,481.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$0.90 B 613.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A$5.37 M-95.74%๐Ÿ‡บ๐Ÿ‡ธ USA